Product Code: ETC7540464 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Companion Diagnostics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 India Companion Diagnostics Market - Industry Life Cycle |
3.4 India Companion Diagnostics Market - Porter's Five Forces |
3.5 India Companion Diagnostics Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 India Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 India Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India leading to a higher demand for personalized treatment options. |
4.2.2 Growing healthcare expenditure and focus on precision medicine in the Indian healthcare sector. |
4.2.3 Rising awareness among healthcare professionals and patients about the benefits of companion diagnostics. |
4.3 Market Restraints |
4.3.1 Lack of standardized regulatory framework for companion diagnostics in India. |
4.3.2 Limited access to advanced diagnostic technologies in rural areas. |
4.3.3 High cost associated with companion diagnostics impacting affordability for a larger section of the population. |
5 India Companion Diagnostics Market Trends |
6 India Companion Diagnostics Market, By Types |
6.1 India Companion Diagnostics Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 India Companion Diagnostics Market Revenues & Volume, By Technology Type, 2021- 2031F |
6.1.3 India Companion Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.4 India Companion Diagnostics Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.1.5 India Companion Diagnostics Market Revenues & Volume, By Next Generation Sequencing (NGS), 2021- 2031F |
6.1.6 India Companion Diagnostics Market Revenues & Volume, By In Situ Hybridization, 2021- 2031F |
6.1.7 India Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Companion Diagnostics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 India Companion Diagnostics Market Revenues & Volume, By Neurology, 2021- 2031F |
6.2.4 India Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 India Companion Diagnostics Market Import-Export Trade Statistics |
7.1 India Companion Diagnostics Market Export to Major Countries |
7.2 India Companion Diagnostics Market Imports from Major Countries |
8 India Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics by healthcare facilities in India. |
8.2 Number of partnerships and collaborations between diagnostic companies and pharmaceutical firms for companion diagnostics development. |
8.3 Rate of incorporation of companion diagnostics in clinical decision-making by healthcare providers in India. |
9 India Companion Diagnostics Market - Opportunity Assessment |
9.1 India Companion Diagnostics Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 India Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 India Companion Diagnostics Market - Competitive Landscape |
10.1 India Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 India Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |